Factors Associated with the Decline of Estimated Glomerular Filtration Rate in Diabetic Patients at Sena Hospital, Phra Nakhon Si Ayutthaya Province
Keywords:
Estimated Glomerular Filtration Rate, Diabetic Kidney Disease, Risk Factors, Sena HospitalAbstract
This survey research by retrospective analytical study aimed to investigate the factors associated with the decline of estimated glomerular filtration rate (eGFR < 60 mL/min/1.73 m²) in diabetic patients at Sena Hospital, Phra Nakhon Si Ayutthaya Province. Data were collected from the medical records of 1,852 patients who received services between October 2023 and September 2024. Data were analyzed using descriptive statistics, Chi-square test, and multiple logistic regression.
The results revealed that 28.9% of the samples had a decline in eGFR. Independent factors significantly associated with eGFR decline were age 65 years and over (aOR = 2.15), uncontrolled HbA1c (aOR = 1.85), duration of diabetes over 10 years (aOR = 1.60), and high triglyceride levels (aOR = 1.45) (p <0.05). In conclusion, proactive risk screening among older adults and strict glycemic and lipid control are crucial for delaying renal function decline in diabetic patients.
References
International Diabetes Federation.(2023). IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation [Internet]. 2021[cited 2023 Dec 15]. Available from: https://diabetesatlas.org/
Selby NM, Taal MW.(2020). An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes Obes Metab. 2020;22(S1):3-15.
Alicic RZ, Rooney MT, Tuttle KR.(2017). Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032-45.
สถาบันวิจัยระบบสาธารณสุข.(2564). รายงานการสำรวจสุขภาพประชาชนไทยโดยการตรวจร่างกาย ครั้งที่ 6 พ.ศ. 2562-2563. นนทบุรี: สถาบันวิจัยระบบสาธารณสุข; 2564.
ระบบคลังข้อมูลด้านการแพทย์และสุขภาพ (Health Data Center: HDC) กระทรวงสาธารณสุข.(2566). รายงานผู้ป่วยเบาหวานและภาวะแทรกซ้อน [อินเตอร์เน็ต]. 2566 [สืบค้นเมื่อ 10 ม.ค. 2567]. เข้าถึงจาก: https://hdcservice.moph.go.th/hdc/main/index.php
Coresh J, Turin CG, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al.(2014). Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA. 2014;311(24):2518-31.
สำนักงานสาธารณสุขจังหวัดพระนครศรีอยุธยา.(2567). รายงานสถานการณ์โรคไม่ติดต่อเรื้อรัง จังหวัดพระนครศรีอยุธยา ปี 2564-2567 [อินเตอร์เน็ต]. 2567 [สืบค้นเมื่อ 15 ม.ค. 2567]. เข้าถึงจาก: https://ayo.hdc.moph.go.th/hdc/main/index.php
Zoppini G, Targher G, Chonchol M, Ortalda V, Abaterusso C, Pichiri I, et al.(2012). Predictors of estimated GFR decline in patients with type 2 diabetes and preserved kidney function. Clin J Am Soc Nephrol. 2012;7(3):401-8.
Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group. KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease. Kidney Int. 2022;102(5S):S1-S127.
Ninomiya T, Perkovic V, de Galan BE, Zoungas S, Pillai A, Jardine M, et al.(2009). Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes. J Am Soc Nephrol. 2009;20(8):1813-21.
de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al.(2022). Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Diabetes Care. 2022;45(12):3075-90.
Heerspink HJL, Stefánsson BV, Correa-Rotter R, Chertow GM, Greene T, Hou FF, et al.(2020). Dapagliflozin in patients with chronic kidney disease. N Engl J Med. 2020;383(15):1436-46.
Levey AS, Gansevoort RT, Coresh J, Inker LA, Heerspink HL, Grams ME, et al.(2020). Change in albuminuria and GFR as end points for clinical trials in early stages of CKD: a scientific workshop sponsored by the National Kidney Foundation in collaboration with the US Food and Drug Administration and European Medicines Agency. Am J Kidney Dis. 2020;75(1):84-104.
